Market Research Report
Sleep Apnea Devices Market Size By Product, By End-use, COVID19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
|Sleep Apnea Devices Market Size By Product, By End-use, COVID19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027|
Published: May 25, 2021
Global Market Insights Inc.
Content info: 200 Pages
Delivery time: 2-3 business days
The global sleep apnea devices market is likely to register significant gains by 2027 owing to the growing geriatric population, increasing number of patients suffering from obstructive sleep apnea disorder, and rising awareness regarding the benefits of sleep centers.
Sleep apnea, as its name suggests, is a sleeping disorder that could lead to serious health issues, if it is left untreated. Most individuals suffering from sleep apnea are likely to be experiencing a condition called OSA (obstructive sleep apnea). This usually happens when there is some physical blockage in the upper airway.
If sleep apnea is not effectively treated, it could cause a greater number of health issues, which includes heart attack, diabetes, heart failure, cardiomyopathy, stroke, and high blood pressure. Untreated sleep apnea might also be responsible for work-related accidents, motor vehicle crashes, and job impairment, along with underachievement in school in adolescents and children.
There are a plethora of medical devices that can correctly help in the treatment of sleep apnea. Among the most common choices are mouth pieces, CPAP machines, as well as specially designed pillows.
The sleep apnea devices market is segmented in terms of product, end-use, and regional landscape.
Based on product, the overall market is classified into diagnostics and therapeutics. Among these, the therapeutics segment was valued at $3,722.0 million in 2020 and is likely to witness robust growth over the coming time period. The increasing number of patients suffering from obstructive sleep apnea disorder worldwide will drive the segmental growth.
The preferred therapeutic devices for the treatment of obstructive sleep apnea is the positive airway pressure device. CPAP is one of the most commonly used PAP devices. The device is set only at one single pressure when in use.
With respect to end-use, the overall sleep apnea devices market is divided into sleep laboratories & hospitals and home care settings & individuals. Sleep laboratories and hospitals end-use segment is estimated to witness more than 8.3% CAGR over the projected time period.
The segment will further reach a valuation of more than $4,922 million by the end of 2027. Increasing access to modern medical equipment, rising awareness regarding sleep centers, and growing focus on offering same-day treatment, and quality care would fuel industry outlook.
On the regional front, in 2020, the sleep apnea devices market in Middle East & Africa was valued at above $112 million. Going forward, the regional market anticipated to grow at CAGR of more than 9.2% over the forthcoming time period. The segment growth can be majorly attributed to the region's growing geriatric population. This, when combined with rapidly increasing awareness regarding sleep apnea as well as other sleep disorders in the region, would majorly outline the market's growth graph.